Mitochondria live in all our cells, but unlike other organelles, mitochondria sport their own DNA—a small, circular strand with about three dozen genes.
Naturally, the code depends upon the assistance of massive proteins called transcription factors, which determine which genes in one’s genome are turned on or off.
The researchers focused on mouse retinal ganglion cells in the study, which project from the retina to the superior colliculus a part of the brain where they synapse onto downstream target neurons.
Results showed that the deletion of a protein, OpgH, in a model bacterium, Caulobacter crescentus, sets off an event cascade that ultimately splits apart the protective, bubble-like cell envelope, eventually killing the cell.
One of the curious features of the thymus, however, is that it serves as the very first organ in our body to become small with age.
New findings out of Emory University are shaking theories of the origin of Alzheimer’s the leading cause of dementia among older adults worldwide.
Monoclonal antibodies revolutionized medicine by introducing a range of targeted therapies against malignant diseases, autoimmune disorders, infectious diseases, and many others. They are engineered from a single clone of cells to bind to antigens with very high precision. This article presents the underlying science behind monoclonal antibodies, including their applications, […]
The first study in the world, conducted recently at the University of Eastern Finland, demonstrates that even in those with a high hereditary risk, type 2 diabetes may be prevented with a balanced diet and frequent exercise. Put another way, regardless of hereditary risk, everyone gains from changing their lifestyle. […]
Ever since the double helix was discovered, researchers have worked to decipher the information contained inside DNA.
A new compound created by researchers at Washington University School of Medicine in St. Louis successfully cures bacterial infections in mice, including those that can cause uncommon but potentially deadly “flesh-eating” disorders. The medicine in question has the potential to be the first in a completely new class of antibiotics, which […]
